Compared with the treatment with MSCs alone, IL‐10 was significantly increased in the combination treatment group, contributing to maintaining the Th1/Th2 balance.[84] Ceria, as an antioxidant for scavenging ROS, has been used in RA treatment. The gene discussed is IL10; the disease is rheumatoid arthritis.